David J. Mazzo
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David J. Mazzo
David J. Mazzo is recorded as CEO at Lisata Therapeutics, Inc. (LSTA). Lisata Therapeutics, Inc. reported in an 8-K filed September 15, 2022 that David J. Mazzo was appointed Chief Executive Officer, effective September 15, 2022.
“Following the closing of the merger, David J. Mazzo, Ph.D., current President and Chief Executive Officer of Caladrius will continue as the Chief Executive Officer of Lisata”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-09-15–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lisata Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- David J. Mazzo, Ph.D. CEO
- David Mazzo CEO, Board Member
- Gregory Brown Chairman
- Gregory Brown, M.D. Chairman
- Dr. Josh Lehrer COO
- Josh Lehrer COO
- Josh Lehrer, M.D., M.Phil., FACC COO
- Tariq Imam General Counsel
- James Nisco Chief Accounting Officer
- Anne Whitaker Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.